It was previously shown that intravenous injection of the racemic compound (DTI) of
l-DTI caused a potent bronchodilating action in anesthetized cats. The present experiments demonstrated that the bronchodilating activity of
l-isomer (
l-DTI) was approx. 2.5 times that of DTI, while the activity of d-isomer (d-DTI) was less than 1/10 that of DTI. Thus, the cardiovascular actions as well as the bronchodilating effects were studied with intravenous administration of
l-DTI and the activities were compared to those of isoproterenol. It was found that the bronchodilating activity of
l-DTI was approx. 1/2.6 that of isoproterenol but the duration of the effect of
l-DTI was longer than that of isoproterenol. On the other hand,
l-DTI produced an increase in heart rate, left ventricular contractile force, dp/dt and cardiac work, these activities being 1/5-1/7 those of isoproterenol. On the other hand, the hypotensive activity of
l-DTI was approx. 1/3 that of isoproterenol and the vasodilating activity of
l-DTI, as examined after intra-arterial injection into the femoral artery, was 1/2.3 that of isoproterenol. The bronchodilating and cardiovascular effects of
l-DTI were inhibited by propranolol. These results suggest that the pharmacological activity of the racemic compound is largely due to its
l-isomer and that the bronchodilating and vasodilating effects of
l-DTI are more potent than the cardiac actions, although
l-DTI is classified as an adrenergic β-stimulant.
View full abstract